U.S. deportation regime’s racialised enforcement exposes systemic failures in asylum law and global refugee governance
Original framing: “Palestinian activist Mahmoud Khalil asks U.S. Supreme Court to hear case” — The Japan Times
The U.S. deportation of Palestinians is not a new phenomenon; it traces back to the 1950s, when the U.S. expelled Palestinian refugees under pressure from Israel. The post-9/11 era intensified this trend, with the Bush administration’s ‘extraordinary rendition’ programs targeting Arab activists, including Palestinians. The 2002 *Hamdan v. Rumsfeld* case set a precedent for denying political asylum to Palestinians based on ‘security’ concerns, a legal strategy later weaponised against Khalil. This historical continuity shows how deportation has been a consistent tool of U.S. foreign policy to suppress Palestinian resistance.
Mahmoud Khalil’s deportation case is not an isolated legal dispute but a microcosm of how the U.S.
asylum system has been weaponised to suppress Palestinian resistance since the 1950s, with post-9/11 policies accelerating this trend. The Supreme Court’s potential intervention is less about justice and more about whether the U.S. will uphold its own legal inconsistencies or double down on a deportation regime that criminalises political dissent. Historical parallels—such as the 1948 Nakba and the U.S. deportation of Palestinian refugees—reveal that this is not a new phenomenon but a continuation of colonial legal strategies. Marginalised voices, including Palestinian legal aid organisations and Arab-American attorneys, have long warned of this bias, yet mainstream coverage obscures these systemic failures. The trickster perspective exposes the absurdity of a ‘neutral’ legal system that deports a man for his activism while ignoring the geopolitical context. Solutions must address this at multiple levels: legally by expanding political asylum protections, structurally by auditing ICE’s racialised enforcement, and globally by engaging refugee governance bodies to create alternative pathways. Without these changes, Khalil’s case will remain a symptom of a much larger illness—one that requires systemic, not just individual, healing.